It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Few studies have considered the influence of motor sign asymmetry on motivated behaviors in de novo drug-naïve Parkinson’s disease (PD). We tested whether motor sign asymmetry could be associated with different motivated behavior patterns in de novo drug-naïve PD. We performed a cross-sectional study in 128 de novo drug-naïve PD patients and used the Ardouin Scale of Behavior in Parkinson’s disease (ASBPD) to assess a set of motivated behaviors. We assessed motor asymmetry based on (i) side of motor onset and (ii) MDS-UPDRS motor score, then we compared right hemibody Parkinson’s disease to left hemibody Parkinson’s disease. According to the MDS-UPDRS motor score, patients with de novo right hemibody PD had significantly lower frequency of approach behaviors (p = 0.031), including nocturnal hyperactivity (p = 0.040), eating behavior (p = 0.040), creativity (p = 0.040), and excess of motivation (p = 0.017) than patients with de novo left hemibody PD. Patients with de novo left hemibody PD did not significantly differ from those with de novo right hemibody PD regarding avoidance behaviors including apathy, anxiety and depression. Our findings suggest that motor sign asymmetry may be associated with an imbalance between motivated behaviors in de novo drug-naïve Parkinson’s disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University Hospital of Besançon, CHRU de Besançon, Neurology Department, Besançon Cedex, France (GRID:grid.411158.8) (ISNI:0000 0004 0638 9213); Université Bourgogne Franche-Comté, Laboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive - UR LINC, Besançon, France (GRID:grid.493090.7) (ISNI:0000 0004 4910 6615)
2 University Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, Grenoble, France (GRID:grid.450307.5) (ISNI:0000 0001 0944 2786)
3 Université Bourgogne Franche-Comté, Laboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive - UR LINC, Besançon, France (GRID:grid.493090.7) (ISNI:0000 0004 4910 6615)
4 CHU de Besançon, Unité de Méthodologie, CIC INSERM 1431, Besançon, France (GRID:grid.411158.8) (ISNI:0000 0004 0638 9213)
5 Hospices Civils de Lyon, Movement Disorders Unit, Neurology Department, Lyon, France (GRID:grid.413852.9) (ISNI:0000 0001 2163 3825); Université Claude Bernard Lyon 1, University of Lyon, Faculté de Médecine Lyon Sud, Lyon, France (GRID:grid.7849.2) (ISNI:0000 0001 2150 7757); CNRS, Institut des Sciences Cognitives Marc Jeannerod, UMR 5229, Bron, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282)
6 Hôpitaux Universitaires de Strasbourg, Service de Neurologie, Strasbourg, France (GRID:grid.412220.7) (ISNI:0000 0001 2177 138X)
7 Hôpitaux Universitaires de Strasbourg, Service de Neurologie, Strasbourg, France (GRID:grid.412220.7) (ISNI:0000 0001 2177 138X); INSERM-U964/CNRS-UMR7104, Université de Strasbourg, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291); Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291)
8 University Hospital of Poitiers, Neurology Department, Poitiers, France (GRID:grid.411162.1) (ISNI:0000 0000 9336 4276); INSERM, CHU de Poitiers, Centre d’Investigation Clinique CIC1402, University of Poitiers, Poitiers, France (GRID:grid.11166.31) (ISNI:0000 0001 2160 6368)
9 EA7280 NPsy-Sydo, Université Clermont Auvergne, Clermont-Ferrand, France (GRID:grid.494717.8) (ISNI:0000 0001 2173 2882); Clermont-Ferrand University Hospital, Neurology Department, Clermont-Ferrand, France (GRID:grid.411163.0) (ISNI:0000 0004 0639 4151)
10 University Hospital of Marseille, Movement Disorders Unit, Neurology Department, Marseille, France (GRID:grid.414336.7) (ISNI:0000 0001 0407 1584)
11 University Hospital of Bern, Department of Neurology, Movement Disorders Center, Bern, Switzerland (GRID:grid.411656.1) (ISNI:0000 0004 0479 0855)




